Study Reports Outcomes of TB-PRACTECAL Clinical Trial for Rifampicin-Resistant Tuberculosis

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 1 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 71%

Health News

TB-PRACTECAL,Clinical Trial,Tuberculosis

Researchers have published the outcomes of the TB-PRACTECAL clinical trial, which assessed the effectiveness and safety of oral bedaquiline, linezolid, and pretomanid-based regimens for treating rifampicin-resistant pulmonary tuberculosis.

In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, and pretomanid (BPaL)-based regimens for pulmonary tuberculosis resistant to rifampicin.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

TAVR and Watchman procedures together yield similar outcomes to blood thinners after TAVR for atrial fibrillationFindings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage occlusion (LAAO) procedure using the Watchman device had similar outcomes as patients getting TAVR in addition to medical therapy or blood thinners.
Source: medical_xpress - 🏆 101. / 51 Read more »